Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Type of Medium
Language
  • 1
    In: The Lancet, Elsevier BV, Vol. 397, No. 10293 ( 2021-06), p. 2476-2486
    Type of Medium: Online Resource
    ISSN: 0140-6736
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2067452-1
    detail.hit.zdb_id: 3306-6
    detail.hit.zdb_id: 1476593-7
    SSG: 5,21
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: JAMA Cardiology, American Medical Association (AMA), Vol. 7, No. 12 ( 2022-12-01), p. 1244-
    Abstract: Although early trials of endovascular renal denervation (RDN) for patients with resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was found to decrease blood pressure (BP) vs sham at 2 months in patients with RHTN taking stable background medications in the Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN TRIO) trial. Objectives To report the prespecified analysis of the persistence of the BP effects and safety of uRDN vs sham at 6 months in conjunction with escalating antihypertensive medications. Design, Setting, and Participants This randomized, sham-controlled, clinical trial with outcome assessors and patients blinded to treatment assignment, enrolled patients from March 11, 2016, to March 13, 2020. This was an international, multicenter study conducted in the US and Europe. Participants with daytime ambulatory BP of 135/85 mm Hg or higher after 4 weeks of single-pill triple-combination treatment (angiotensin-receptor blocker, calcium channel blocker, and thiazide diuretic) with estimated glomerular filtration rate (eGFR) of 40 mL/min/1.73 m 2 or greater were randomly assigned to uRDN or sham with medications unchanged through 2 months. From 2 to 5 months, if monthly home BP was 135/85 mm Hg or higher, standardized stepped-care antihypertensive treatment starting with aldosterone antagonists was initiated under blinding to treatment assignment. Interventions uRDN vs sham procedure in conjunction with added medications to target BP control. Main Outcomes and Measures Six-month change in medications, change in daytime ambulatory systolic BP, change in home systolic BP adjusted for baseline BP and medications, and safety. Results A total of 65 of 69 participants in the uRDN group and 64 of 67 participants in the sham group (mean [SD] age, 52.4 [8.3] years; 104 male [80.6%]) with a mean (SD) eGFR of 81.5 (22.8) mL/min/1.73 m 2 had 6-month daytime ambulatory BP measurements. Fewer medications were added in the uRDN group (mean [SD], 0.7 [1.0] medications) vs sham (mean [SD], 1.1 [1.1] medications; P = .045) and fewer patients in the uRDN group received aldosterone antagonists at 6 months (26 of 65 [40.0%] vs 39 of 64 [60.9%] ; P = .02). Despite less intensive standardized stepped-care antihypertensive treatment, mean (SD) daytime ambulatory BP at 6 months was 138.3 (15.1) mm Hg with uRDN vs 139.0 (14.3) mm Hg with sham (additional decreases of −2.4 [16.6] vs −7.0 [16.7] mm Hg from month 2, respectively), whereas home SBP was lowered to a greater extent with uRDN by 4.3 mm Hg (95% CI, 0.5-8.1 mm Hg; P  = .03) in a mixed model adjusting for baseline and number of medications. Adverse events were infrequent and similar between groups. Conclusions and Relevance In this study, in patients with RHTN initially randomly assigned to uRDN or a sham procedure and who had persistent elevation of BP at 2 months after the procedure, standardized stepped-care antihypertensive treatment escalation resulted in similar BP reduction in both groups at 6 months, with fewer additional medications required in the uRDN group. Trial Registration ClinicalTrials.gov Identifier: NCT02649426
    Type of Medium: Online Resource
    ISSN: 2380-6583
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2022
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: JAMA Cardiology, American Medical Association (AMA), Vol. 8, No. 5 ( 2023-05-01), p. 464-
    Abstract: Ultrasound renal denervation (uRDN) was shown to lower blood pressure (BP) in patients with uncontrolled hypertension (HTN). Establishing the magnitude and consistency of the uRDN effect across the HTN spectrum is clinically important. Objective To characterize the effectiveness and safety of uRDN vs a sham procedure from individual patient-level pooled data across uRDN trials including either patients with mild to moderate HTN on a background of no medications or with HTN resistant to standardized triple-combination therapy. Data Sources A Study of the ReCor Medical Paradise System in Clinical Hypertension (RADIANCE-HTN SOLO and TRIO) and A Study of the ReCor Medical Paradise System in Stage II Hypertension (RADIANCE II) trials. Study Selection Trials with similar designs, standardized operational implementation (medication standardization and blinding of both patients and physicians to treatment assignment), and follow-up. Data Extraction and Synthesis Pooled analysis using individual patient-level data using linear regression models to compare uRDN with sham across the trials. Main Outcomes and Measures The primary outcome was baseline-adjusted change in 2-month daytime ambulatory systolic BP (dASBP) between groups. Results A total of 506 patients were randomized in the 3 studies (uRDN, 293; sham, 213; mean [SD] age, 54.1 [9.3] ; 354 male [70.0%]). After a 1-month medication stabilization period, dASBP was similar between the groups (mean [SD] , uRDN, 150.3 [9.2] mm Hg; sham, 150.8 [10.5] mm Hg). At 2 months, dASBP decreased by 8.5 mm Hg to mean (SD) 141.8 (13.8) mm Hg among patients treated with uRDN and by 2.9 mm Hg to 147.9 (14.6) mm Hg among patients treated with a sham procedure (mean difference, −5.9; 95% CI, −8.1 to −3.8 mm Hg; P   & amp;lt; .001 in favor of uRDN). BP decreases from baseline with uRDN vs sham were consistent across trials and across BP parameters (office SBP: −10.4 mm Hg vs −3.4 mm Hg; mean difference, −6.4 mm Hg; 95% CI, −9.1 to –3.6 mm Hg; home SBP: −8.4 mm Hg vs −1.4 mm Hg; mean difference, −6.8 mm Hg; 95% CI, −8.7 to −4.9 mm Hg, respectively). The BP reductions with uRDN vs sham were consistent across prespecified subgroups. Independent predictors of a larger BP response to uRDN were higher baseline BP and heart rate and the presence of orthostatic hypertension. No differences in early safety end points were observed between groups. Conclusions and Relevance Results of this patient-level pooled analysis suggest that BP reductions with uRDN were consistent across HTN severity in sham-controlled trials designed with a 2-month primary end point to standardize medications across randomized groups. Trial Registration ClinicalTrials.gov Identifier: NCT02649426 and NCT03614260
    Type of Medium: Online Resource
    ISSN: 2380-6583
    Language: English
    Publisher: American Medical Association (AMA)
    Publication Date: 2023
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Canadian Society of Hospital Pharmacists (CSHP) ; 2019
    In:  The Canadian Journal of Hospital Pharmacy Vol. 72, No. 3 ( 2019-06-25)
    In: The Canadian Journal of Hospital Pharmacy, Canadian Society of Hospital Pharmacists (CSHP), Vol. 72, No. 3 ( 2019-06-25)
    Abstract: ABSTRACTBackground: In many studies on documentation, the data are self-reported, which makes it difficult to know the actual level of documen-tation by pharmacists in patients’ medical records. The literature assessing documentation by clinical pharmacists in health care centres is limited. Objective: To assess the level of documentation in patients’ medical records by clinical pharmacists at one large urban hospital.Methods: This retrospective observational study included all patients who were followed by a clinical pharmacist during their stay in the Centre hospitalier de l’Université de Montreal between July 1 and October 31, 2016. The primary outcome, the level of documentation in patients’ medical records, was categorized as minimal, sufficient, or extensive. The quality of notes and the impact of pharmacy students and residents on documentation were evaluated as secondary outcomes. Results: A total of 779 patient charts from 4 inpatient units were included in the analysis. Of these, 563 (72.3%) were considered to have minimal documentation (at least 1 intervention described in writing), 432 (55.5%) had sufficient documentation (at least 1 note written during the patient’s hospitalization), and 81 (10.4%) had extensive documentation (appropriate number of notes in relation to duration of hospitalization). Medication reconciliation performed by pharmacists at the time of admission was documented in 696 (89.3%) of patients’ records. The presence of students or residents on a clinical unit was associated with a significant increase in the percentage of charts with at least 1 follow-up note (23.6% [120/508] with students/residents versus 12.5% [34/271] without students/residents; p 〈 0.001) and the mean number of follow-up notes (0.59 versus 0.23, respectively; p 〈 0.001) but had no effect on other variables. Of a total of 777 notes written by a pharmacist, the overall conformity with pre-established criteria was 56.8% (441/777), and conformity was 43.4% (139/320), 75.1% (272/362), and 31.6% (30/95) for admission, follow-up, and discharge notes, respectively. Conclusions: Documentation by clinical pharmacists in patients’ medical records could be improved to achieve the stated goal of the American Society of Health-System Pharmacists and the Canadian Society of Hospital Pharmacists, that all significant clinical recommendations or interventions should be documented.RÉSUMÉContexte : Les données de bon nombre d’études portant sur la tenue des dossiers médicaux sont autodéclarées, ce qui fait qu’il est difficile de savoir exactement dans quelle mesure les pharmaciens consignent les informations dans les dossiers médicaux des patients. Il n’existe que peu d’études évaluant la tenue des dossiers par les pharmaciens cliniques dans les centres de soins de santé. Objectif : Évaluer dans quelle mesure les pharmaciens cliniciens d’un important hôpital urbain consignent l’information dans les dossiers médicaux des patients. Méthodes : La présente étude d’observation rétrospective englobait tous les patients ayant été suivis par un pharmacien clinicien pendant leur séjour au Centre hospitalier de l’Université de Montréal entre le 1er juillet et le 31 octobre 2016. Le principal paramètre d’évaluation, soit le degré de rigueur des inscriptions dans les dossiers médicaux des patients, entrait dans l’une des trois catégories suivantes : minimal, suffisant ou exhaustif. La qualité des notes et l’effet de la participation d’étudiants et de résidents en pharmacie à la tenue des dossiers ont servi de paramètres d’évaluation secondaires. Résultats : L’analyse a porté sur 779 dossiers médicaux de patients provenant de quatre services hospitaliers. Les investigateurs ont considéré que 563 d’entre eux (72,3 %) appartenaient à la catégorie « minimal » (au moins une intervention consignée par écrit), 432 (55,5 %) se situaient dans la catégorie « suffisant » (au moins une note rédigée au cours de l’hospitalisation du patient) et 81 (10,4 %) se rangeaient dans la catégorie « exhaustif » (nombre adéquat de notes en fonction à la durée de l’hospitalisation). Les bilans comparatifs des médicaments établis par des pharmaciens au moment de l’admission ont été consignés dans 696 (89,3 %) dossiers médicaux de patients. On a associé la présence d’étudiants ou de résidents dans une unité clinique à une hausse significative du pourcentage de dossiers médicaux affichant au moins une note de suivi (23,6 % [120/508] avec des étudiants / résidents contre 12,5 % [34/271] sans étudiants / résidents; p 〈 0,001) et du nombre moyen de notes de suivi (respectivement 0,59 contre 0,23; p 〈 0,001), mais leur présence n’a été associée à aucun autre effet sur les autres variables. Le taux de conformité globale aux critères préétablis des 777 notes rédigées par un pharmacien était de 56,8 % (441/777) et le taux de conformité des notes d’admission, de suivi et de congé était respectivement de 43,4 % (139/320), 75,1 % (272/362) et 31,6 % (30/95). Conclusions : La tenue des dossiers médicaux de patients par les pharmaciens cliniciens devrait s’améliorer pour qu’elle atteigne l’objectif établi par l’American Society of Health-System Pharmacists et la Société canadienne des pharmaciens d’hôpitaux, qui veut que toutes les recommandations et interventions cliniques d’importance soient consignées.
    Type of Medium: Online Resource
    ISSN: 1920-2903 , 0008-4123
    Language: Unknown
    Publisher: Canadian Society of Hospital Pharmacists (CSHP)
    Publication Date: 2019
    detail.hit.zdb_id: 2107012-X
    SSG: 15,3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    In: Brain Stimulation, Elsevier BV, Vol. 6, No. 6 ( 2013-11), p. 837-844
    Type of Medium: Online Resource
    ISSN: 1935-861X
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2013
    detail.hit.zdb_id: 2404774-0
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    CAIRN ; 2023
    In:  Gestion Vol. Vol. 48, No. 3 ( 2023-8-31), p. 68-71
    In: Gestion, CAIRN, Vol. Vol. 48, No. 3 ( 2023-8-31), p. 68-71
    Abstract: Tout au long de sa vie, un employé passera en moyenne 90 000 heures au boulot. C’est beaucoup de temps pour être malheureux ! Sachant qu’un travailleur mécontent peut avoir une influence négative sur les résultats d’une organisation, qu’en est-il d’un employé heureux au travail ? Voilà le questionnement qui a mené à la réalisation du projet Happy au Département de pharmacie du Centre hospitalier de l’Université de Montréal (CHUM).
    Type of Medium: Online Resource
    ISSN: 0701-0028
    Language: French
    Publisher: CAIRN
    Publication Date: 2023
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    In: Research in Social and Administrative Pharmacy, Elsevier BV, Vol. 17, No. 1 ( 2021-01), p. 1990-1996
    Type of Medium: Online Resource
    ISSN: 1551-7411
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2021
    detail.hit.zdb_id: 2192059-X
    SSG: 15,3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    In: Journal of Child Psychology and Psychiatry, Wiley, Vol. 64, No. 3 ( 2023-03), p. 388-396
    Abstract: Peer victimisation has been associated with depressive symptoms during adolescence, however not all peer victimised adolescents will exhibit such symptoms. This study tested whether having a genetic predisposition to developing depression increased the risk of experiencing depressive symptoms in peer victimised youth. To date, no study has explored such gene–environment interaction using a polygenic risk score for depression (PRS‐depression) in the context of peer victimisation and depressive symptoms in adolescence. Methods The sample included 748 participants born in 1997/98 from the Quebec Longitudinal Study of Child Development with genotype data and prospectively collected information on peer victimisation (12–13 years) obtained from both self‐ and teacher‐reports, as well as self‐reported depressive symptoms (15–17 years). The PRS‐depression was based on the genome‐wide association meta‐analysis of broad depression by Howard et al. (2019). Results Self‐ and teacher‐reported peer victimisation in early adolescence were both associated with depressive symptoms in adolescence (β = 0.34, p   〈  .001; β = 0.14, p  = .001 respectively), and this association remained significant when accounting for PRS‐depression (β = 0.33, p   〈  .001; β = 0.13, p  = .002 respectively). PRS‐depression was independently associated with depressive symptoms, but there was no significant PRS‐depression by peer victimisation interaction (self‐reported and teacher‐reported). PRS‐depression was correlated with self‐reported, but not teacher‐reported, peer victimisation. Conclusions Our findings suggested that a partial measure of an individual's genetic predisposition to depression, as measured by PRS‐depression, and being exposed to peer victimisation (self‐ and teacher‐reported) were independently associated with depressive symptoms in adolescence. Furthermore, PRS‐depression did not exacerbate the risk of depressive symptoms among adolescents who had been peer victimised. Lastly, we found evidence of a gene–environment correlation between PRS‐depression and self‐reported peer victimisation. Future studies are needed to replicate this finding and to further understand the role of genetic predispositions in experiencing depressive symptoms following peer victimisation.
    Type of Medium: Online Resource
    ISSN: 0021-9630 , 1469-7610
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 1470297-6
    SSG: 5,2
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    SAGE Publications ; 1999
    In:  Perceptual and Motor Skills Vol. 88, No. 2 ( 1999-04), p. 355-362
    In: Perceptual and Motor Skills, SAGE Publications, Vol. 88, No. 2 ( 1999-04), p. 355-362
    Abstract: The aim of this study was to examine a possible relation between the speed of information processing, as measured by simple and choice visual RT, and problem-solving, as measured by the Tower of Hanoi test. For 20 normal teenagers, performing all tests, significant correlations were found between choice RT and both measures of performance on the Tower of Hanoi, number of disk moves, and time taken to complete the task. Simple RT was correlated with Completion time but not with the number of moves, while the reverse pattern was discerned for decision time. Choice movement time was also associated with both measures, but simple movement time was not. These results are consistent with the hypothesis of a common neurobiological basis to information-processing speed and executive functions.
    Type of Medium: Online Resource
    ISSN: 0031-5125 , 1558-688X
    Language: English
    Publisher: SAGE Publications
    Publication Date: 1999
    detail.hit.zdb_id: 2066876-4
    SSG: 5,2
    SSG: 7,11
    SSG: 31
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    In: American Journal of Orthopsychiatry, American Psychological Association (APA), Vol. 70, No. 4 ( 2000), p. 501-509
    Type of Medium: Online Resource
    ISSN: 1939-0025 , 0002-9432
    RVK:
    Language: English
    Publisher: American Psychological Association (APA)
    Publication Date: 2000
    detail.hit.zdb_id: 2065804-7
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages